ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.
Molecular Weight:
954
Purity:
>98%
Formula:
C42H62F3N11O11
* VAT and and shipping costs not included. Errors and price changes excepted
